BBR induces autophagic cell death and apoptosis in human gastric cancer, glioblastoma multiforme (GBM), breast cancer, and hepatoma cells by the activation of Beclin1, as well as the inhibition of the mTOR signaling pathway [160,161]. Here, BECN1 is linked to breast carcinoma.